Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Ionis Pharmaceuticals
company
About
Ionis Pharmaceuticals specializes in the discovery and development of RNA-targeted drugs.
- Carlsbad,California,United States
- 251 - 500
- http://www.ionispharma.com
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $201.25M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 1989
- Number Of Employee
- 251 - 500
- Operating Status
- Active
- Stock Symbol
- nasdaq:IONS
- Legal Name
- Ionis Pharmaceuticals, Inc.
- Also Known As
- Isis Pharmaceuticals
Ionis Pharmaceuticals is a pharmaceutical company. It specializes in RNA-targeted drug discovery and development. Ionis has developed antisense technology, an efficient, broadly applicable drug discovery platform that can treat diseases where no other therapeutic approaches have proven effective.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$751.25M
Ionis Pharmaceuticals has raised a total of
$751.25M
in funding over 2 rounds. Their latest funding was raised on
Apr 8, 2021 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 8, 2021 | Post-IPO Debt | $550M | — | — | — | Detail |
| Aug 27, 2012 | Post-IPO Debt | $201.25M | — | — | — | Detail |
| May 24, 1991 | IPO | — | — | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
4
3
Ionis Pharmaceuticals has made 4 investments. Their most recent investment was on
Nov 14, 2022, when Metagenomi raised $80M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 14, 2022
Metagenomi
|
Corporate Round | $80M | Artificial Intelligence | Yes |
|
Jan 5, 2021
Aro Biotherapeutics
|
Series A | $88M | Biotechnology | — |
|
Jan 9, 2020
Empirico
|
Series A | $17M | Biotechnology | Yes |
|
Mar 1, 2007
Atlantic Healthcare
|
Seed | $6.80M | Biotechnology | Yes |
Employee Profiles
Number of Employee Profiles
38
Ionis Pharmaceuticals has 38 current employee profiles, including
Employee Michael Tanowitz
Employee
Executive
Employee
Executive
Executive
Acquisition
Ionis Pharmaceuticals has acquired 1 organizations. Their most recent acquisition was Akcea Therapeutics on Aug 31, 2020. They acquired Akcea Therapeutics for $500M.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Aug 31, 2020
Akcea Therapeutics
|
Biotechnology | acquisition | $ 500M | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
